Halma acquires ophthalmic instruments maker Surgistar for $90m

HLMA

Halma plc (LON:HLMA), the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, has announced that it has acquired Surgistar, Inc. (Surgistar) as a bolt-on for its Healthcare Sector company, MicroSurgical Technology, Inc. (MST).

Founded over 20 years ago and based in California, Surgistar designs and manufactures ophthalmic surgical instruments and devices. Its product portfolio includes blades, cannulas and trephines, which are manufactured using highly automated processes that help ensure consistent quality and sharpness.

The cash consideration for Surgistar is $90m (approximately £67m), on a cash- and debt-free basis, to be funded from Halma’s existing facilities.

Marc Ronchetti, Group Chief Executive of Halma, commented: “Surgistar’s differentiated product range is highly complementary to MST’s and further strengthens Halma’s ophthalmic product offering. The acquisition enhances MST’s manufacturing capabilities and supports its long-term growth through MST’s existing direct and global channels. We are excited to see our existing companies expand their capabilities through bolt-on acquisitions and delighted to welcome Surgistar to Halma.”

Share on:

Latest Company News

Halma raises profit margin guidance after strong first half

Halma expects a 23.5%–24% Adjusted EBIT margin for 2027 after strong first-half growth and £515m of acquisitions.

Halma to acquire water quality monitoring specialist Pyxis for $170m

Halma has agreed to acquire Pyxis, a US-based provider of water quality monitoring and analysis technology, for an initial $170m, with up to $30m in additional earn-out payments. Pyxis will join Halma’s Environmental & Analysis Sector.

Halma completes sale of NovaBone for $60m

Halma has completed the sale of NovaBone Products LLC and its subsidiaries to Isto Biologics for total consideration of $60m on a cash and...

Halma expands healthcare portfolio with Dreampath acquisition

Halma has announced the acquisition of Dreampath, adding tissue sample traceability and storage capabilities to its Healthcare Sector.

Halma reports full-year results and proposes higher final dividend

Halma has released full-year results for the year to 31 March 2026 and proposed a higher final dividend.

Halma acquires ophthalmic instruments maker Surgistar for $90m

Halma has acquired California-based Surgistar, a manufacturer of ophthalmic surgical instruments and devices, for $90 million as a bolt-on to MicroSurgical Technology, strengthening its ophthalmic product offering and manufacturing capabilities.

    Search